New Risk • Jun 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 70% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Market cap is less than US$100m (₩85.9b market cap, or US$56.3m). Announcement • May 22
LabGenomics Co., Ltd. announced that it has received KRW 20 billion in funding On May 20, 2026, LabGenomics Co., Ltd. has closed the transaction. Announcement • May 13
LabGenomics Co., Ltd. announced that it expects to receive KRW 20 billion in funding LabGenomics Co., Ltd. announces a private placement with Stick Litmus Co., Ltd. to issue Series 5 Unregistered Unsecured Private Convertible Bonds for gross proceeds of KRW 20,000,000,000 on May 12, 2026. Expected closing date of the transaction is May 20, 2026. Interest rate of the Notes is 0% and Maturity interest rate is 5%. Maturity date of the Notes is May 20, 2029. Notes are convertible into 13,642,564 shares at a conversion price of KRW 1,466. Conversion billing period starts from May 20, 2027 and ends on April 20, 2029.